Our Partnerships
| Collaboration Type | What We Offer | Your Impact |
|---|---|---|
| Technology licensing | Access to a portfolio of patented assets and research materials | Gain a competitive edge and accelerate your R&D pipeline |
| Co-development | Joint pathways to build, validate, and scale next-generation technologies and instrumentation | Share risk to innovate and unlock new opportunities |
| Sponsored research | Custom research projects tailored to solve your industry challenges | Leverage our world-class labs and top-tier talents |
| Scientific services | Access to high-end technical expertise, advanced instrumentation platforms, and testing workflows | Obtain reliable data and specialized analysis on demand |
| Spin-off investment | Early-stage investment opportunities in new venture | Get in on the ground floor of disruptive health innovations |
We constantly work on creative new ways to connect industry and our scientists and create dedicated infrastructure to foster technology transfer and collaborations. We are developing a Validation Lab enabling industry partners to evaluate our technologies for their specific applications.
This mission takes a giant leap forward with our new AI2M center, which establishes specialized hubs across Berlin to co-develop “AI – Accelerated Molecular Innovations in Medicine” alongside industry partners.
Example in Action:
The MDC-Bruker Center of Excellence for Single Cell Omics
We actively bring industry directly into our research space to accelerate biomedical discoveries. Our partnership with Bruker to establish the Center of Excellence for Single Cell Omics perfectly illustrates this. By embedding corporate technology experts directly within our facilities, we have created a highly interactive ecosystem where shared resources, joint R&D projects, and a dynamic exchange of ideas fast-track innovations from the lab to clinical relevance.
Get in touch to explore how we can work together
Dr. Marie Vidal, Senior BD Manager
Kseniia Choni, BD Manager